Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

European scientists identify a gene network that predisposes to type 1 diabetes

09.09.2010
Type 1 diabetes is a metabolic disorder characterized by high blood sugar levels because the insulin-producing pancreatic beta cells are attacked and destroyed by the body's immune system. The exact cause is unknown, but viral or environmental trigger as well as a genetic susceptibility are thought to be major determinants of development of the disease. Type 1 diabetes is fatal unless treated with insulin.

Within a large international collaborative study, lead by Norbert Hübner (Max-Delbrück-Centrum für Molekulare Medizin (MDC) in Berlin-Buch, Germany) and Stuart Cook (Imperial College London, UK), European scientists have now identified a gene network modulating type 1 diabetes risk. Furthermore, the scientists identified a key receptor within this important genetic framework.

The current multidimenstional approach was based on genetic as well as gene expression data in different species and provided new insights in respect that the innate viral response pathway and immune cells called macrophages are also implicated in T1D.

Transcription factors play a major role in regulating gene expression by binding to specific target sequences close to the gene of interest. Importantly, a transcription factor often regulates not only one gene but whole gene networks. “In recent years a multiplicity of risk genes has been discovered which play an important role in the development of various diseases. Despite this, though, the molecular mechanism that influences the onset of the diseases has not yet been fully understood” explains a leader of this currently published study, Prof. Dr. Norbert Huebner. “We have identified a transcription factor which controls a gene network in which a well known Diabetes mellitus Type 1 risk gene occurs.

“Further analysis of the data”, concluded Prof. Huebner, “revealed that the IDIN (interferon regulatory factor 7 (IRF71)-driven inflammatory network ) gene essentially influences Diabetes mellitus type 1 risk via the receptor EBI2 which regulates IDIN and thus plays a role in the development of this autoimmune disease. Additionally we were able to show the involvement of macrophages in the pathogenesis as well as able to show that similar signaling pathways are involved in Diabetes mellitus type 1 and Epstein Barr virus infection.”

More broadly, the study is of interest because it successfully combines gene networks and DNA sequence variation to emphasize the fact that regulatory regions that perturb biological networks can have an important role in disease risk.

“The present study is an extraordinary example of combining different genetic approaches, involving genome wide expression data from rats and humans as well as genome wide association data resulting in new and exciting insights into disease pathogenesis” explained Prof. Dr. Heribert Schunkert, coordinator of Cardiogenics. “In addition, it is a success story based on international collaboration between working groups and consortia with very different expertise” adds Prof. Dr. Jeanette Erdmann, scientific project manager of Cardiogenics.

The Cardiogenics consortium (www.cardiogenics.eu) has played its role in this work bringing experimental monocyte and macrophage expression data and expertise from its own focus on the assessment of heart attack risk to aid understanding of another important common disease. This EU project has gathered together leading research groups from six countries (Germany, United Kingdom, France, The Netherlands, Sweden, and Italy) to build a multi-disciplinary team to meet the challenge of improving cardiovascular healthcare. In addition to clinical teams, the consortium consists of academic groups specialized in human genetics, genetic epidemiology, bioinformatics, transcriptomics, and proteomics. In addition, the consortium has been supported by the Welcome Trust Sanger Institute, Europe's premier genome centre.

A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk

M. Heinig*, E. Petretto*, C. Wallace, L. Bottolo, M. Rotival, H. Lu, Y. Li, R. Sarwar, S.R. Langley, A. Bauerfeind, O. Hummel, Y.-A. Lee, S. Paskas, C. Rintisch, K. Saar, .J Cooper, R. Buchan, E.E. Gray, J.G. Cyster, Cardiogenics Consortium, J. Erdmann, C. Hengstenberg, S. Maouche, W.H. Ouwehand, C.M. Rice, N.J. Samani, H. Schunkert, A.H. Goodall, H. Schulz, H. Roider, M. Vingron, S. Blankenberg, T. Münzel, T. Zeller, S. Szymczak, A. Ziegler, L. Tiret, D.J. Smyth, M. Pravenec, T.J. Aitman, F. Cambien, D. Clayton, J.A. Todd, N. Hubner* und S.A. Cook* (*contributed equally)

Nature advance online publication 08.09.2010: http://www.nature.com/

Contact
Prof. Dr. Jeanette Erdmann and Prof. Dr. Heribert Schunkert
Cardiogenics - coordinating office
University of Lübeck
Ratzeburger Allee 160
23538 Lübeck, Germany
phone: 0049-451-5002501
fax: 0049-451-5006437
e-mail: info@cardiogenics.eu

Rüdiger Labahn | idw
Further information:
http://www.cardiogenics.eu
http://www.nature.com/

More articles from Life Sciences:

nachricht Joining forces for immune research
13.08.2018 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft

nachricht The “TRiC” to folding actin
10.08.2018 | Max-Planck-Institut für Biochemie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

Im Focus: World record: Fastest 3-D tomographic images at BESSY II

The quality of materials often depends on the manufacturing process. In casting and welding, for example, the rate at which melts solidify and the resulting microstructure of the alloy is important. With metallic foams as well, it depends on exactly how the foaming process takes place. To understand these processes fully requires fast sensing capability. The fastest 3D tomographic images to date have now been achieved at the BESSY II X-ray source operated by the Helmholtz-Zentrum Berlin.

Dr. Francisco Garcia-Moreno and his team have designed a turntable that rotates ultra-stably about its axis at a constant rotational speed. This really depends...

Im Focus: A molecular switch may serve as new target point for cancer and diabetes therapies

If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A mechanism recently discovered by scientists at the Leibniz- Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin and at the University of Geneva has a crucial influence on such signaling cascades and may be an important key for the future development of therapies against these diseases. The results of the study have just been published in the prestigious scientific journal 'Molecular Cell'.

Cell growth and cell differentiation as well as the release and efficacy of hormones such as insulin depend on the presence of lipids. Lipids are small...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

NRL's sun imaging telescopes fly on NASA Parker Solar Probe

13.08.2018 | Physics and Astronomy

UT-ORNL team makes first particle accelerator beam measurement in six dimensions

13.08.2018 | Physics and Astronomy

ASU astrophysicist helps discover that ultrahot planets have starlike atmospheres

13.08.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>